SBIR/STTR Research Award

High-resolution optical imaging and spectroscopy instrument for real-time characterization of soft tissue constructs

Award identifier e506b7d744f122d43da2384dedc28d82e709de7ab144fbdd536289851c43186eAwarding agency Department of Defense · Defense Health Agency

Award amount

$999,793

Program and phase

SBIR · Phase II

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Health Agency
Recipient company
PHYSICAL SCIENCES INC.
Proposal award date
2013-04-10
Contract end date
2015-04-28
UEI
RMG1AZ1ZH8Q7
Solicitation number
2011.2
Topic code
OSD11-H08

Research abstract

Traumatic injuries, especially in the combat setting, are often associated with significant tissue loss and morbidity. Immediate reconstruction is often needed to prevent further morbidity and degradation of soldier health status. Novel regenerative medicine approaches, including grafting of engineered tissue have the potential to address this problem. However, the absence of adequate tools for testing tissue morphology and viability before grafting makes this process very difficult. Thus, there is an urgent need for a technology that will enable real time, noninvasive, three-dimensional quantitative assessment of growing ex vivo engineered tissue to assess cell state and viability, microstructure, and overall tissue state and maturity for transplantation. In a Phase I study, Physical Sciences Inc. (PSI) in collaboration with the Center for Regenerative Medicine at the Massachusetts General Hospital (MGH), investigated the use of combined Raman spectroscopy-high resolution optical imaging for in vitro characterization of engineered tissue constructs. The Phase I study has successfully demonstrated the suitability of this approach for nondestructive characterization of tissue constructs. As a result, an advanced instrument, suitable for research use at MGH, Center for Regenerative Medicine is proposed to be developed and fully evaluated in a Phase II study.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

1,763 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $698,949,224. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, National Science Foundation, Environmental Protection Agency

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.